- Home
- CLPT vs EBS Comparison
CLPT vs EBS Comparison
Compare CLPT & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLPT | EBS |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.9M | 413.3M |
| IPO Year | 2009 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CLPT | EBS |
|---|---|---|
| Price | $16.82 | $5.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $20.00 | $12.00 |
| AVG Volume (30 Days) | 571.2K | ★ 1.3M |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | ★ N/A | N/A |
| Revenue | $36,971,000.00 | ★ $742,900,000.00 |
| Revenue This Year | $45.67 | $1.29 |
| Revenue Next Year | $19.51 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.78 | N/A |
| 52 Week Low | $8.27 | $4.36 |
| 52 Week High | $30.10 | $14.06 |
Technical Indicators
Market Signals| Indicator | CLPT | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 53.10 | 39.59 |
| Support Level | $13.25 | $4.36 |
| Resistance Level | $16.54 | $8.73 |
| Average True Range (ATR) | 0.56 | 0.32 |
| MACD | 0.12 | 0.10 |
| Stochastic Oscillator | 80.87 | 57.76 |
Price Performance
Historical ComparisonAbout CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.